254 related articles for article (PubMed ID: 29028854)
41. Cutaneous T-cell lymphoma-Focus on some problems, and some solutions.
Beltraminelli H
Hematol Oncol; 2023 Jun; 41 Suppl 1():20-24. PubMed ID: 37294972
[TBL] [Abstract][Full Text] [Related]
42. Mycosis fungoides and sezary syndrome: an update.
Kim EJ; Lin J; Junkins-Hopkins JM; Vittorio CC; Rook AH
Curr Oncol Rep; 2006 Sep; 8(5):376-86. PubMed ID: 16901399
[TBL] [Abstract][Full Text] [Related]
43. A new nail in the CTCL coffin.
Lessin SR
J Invest Dermatol; 2006 Nov; 126(11):2368-9. PubMed ID: 17041618
[TBL] [Abstract][Full Text] [Related]
44. Cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia: clinical characteristics, temporal relationships, and survival data in a series of 14 patients at Mayo Clinic.
Chang MB; Weaver AL; Brewer JD
Int J Dermatol; 2014 Aug; 53(8):966-70. PubMed ID: 24134412
[TBL] [Abstract][Full Text] [Related]
45. Mycosis fungoides and Sézary syndrome: a population-wide study on prevalence and health care use in Finland in 1998-2016.
Keto J; Hahtola S; Linna M; Väkevä L
BMC Health Serv Res; 2021 Feb; 21(1):166. PubMed ID: 33618714
[TBL] [Abstract][Full Text] [Related]
46. Cutaneous T-cell lymphoma (mycosis fungoides).
Lorincz AL
Lancet; 1996 Mar; 347(9005):871-6. PubMed ID: 8622396
[No Abstract] [Full Text] [Related]
47. [Treatment of mycosis fungoides and Sézary syndrome].
Nicolay JP; Assaf C
Hautarzt; 2017 Sep; 68(9):702-710. PubMed ID: 28770285
[TBL] [Abstract][Full Text] [Related]
48. SOHO State-of-the-Art Updates and Next Questions: A Modern Approach to the Systemic Treatment of Advanced CTCL.
Brazel D; Pinter-Brown L
Clin Lymphoma Myeloma Leuk; 2023 Jun; 23(6):401-409. PubMed ID: 37061415
[TBL] [Abstract][Full Text] [Related]
49. Mycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapy.
Kuzel TM; Roenigk HH; Rosen ST
J Clin Oncol; 1991 Jul; 9(7):1298-313. PubMed ID: 2045869
[TBL] [Abstract][Full Text] [Related]
50. Immunotherapy for Cutaneous T-Cell Lymphoma: Current Landscape and Future Developments.
Sivanand A; Surmanowicz P; Alhusayen R; Hull P; Litvinov IV; Zhou Y; Gniadecki R
J Cutan Med Surg; 2019; 23(5):537-544. PubMed ID: 31353944
[TBL] [Abstract][Full Text] [Related]
51. Cutaneous Lymphomas - Part I: Mycosis Fungoides, Sézary Syndrome, and CD30
Pujol RM; Gallardo F
Actas Dermosifiliogr (Engl Ed); 2021 Jan; 112(1):14-23. PubMed ID: 32896500
[TBL] [Abstract][Full Text] [Related]
52. Mycosis fungoides and Sézary syndrome.
Hwang ST; Janik JE; Jaffe ES; Wilson WH
Lancet; 2008 Mar; 371(9616):945-57. PubMed ID: 18342689
[TBL] [Abstract][Full Text] [Related]
53. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
54. Mycosis fungoides and the Sézary syndrome.
Kim YH; Hoppe RT
Semin Oncol; 1999 Jun; 26(3):276-89. PubMed ID: 10375085
[TBL] [Abstract][Full Text] [Related]
55. Interleukin-15 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
Leroy S; Dubois S; Tenaud I; Chebassier N; Godard A; Jacques Y; Dréno B
Br J Dermatol; 2001 May; 144(5):1016-23. PubMed ID: 11359391
[TBL] [Abstract][Full Text] [Related]
56. How we treat mycosis fungoides and Sézary syndrome.
Khan N; Noor SJ; Horwitz S
Clin Adv Hematol Oncol; 2021 Sep; 19(9):573-581. PubMed ID: 34495021
[No Abstract] [Full Text] [Related]
57. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.
Trautinger F; Eder J; Assaf C; Bagot M; Cozzio A; Dummer R; Gniadecki R; Klemke CD; Ortiz-Romero PL; Papadavid E; Pimpinelli N; Quaglino P; Ranki A; Scarisbrick J; Stadler R; Väkevä L; Vermeer MH; Whittaker S; Willemze R; Knobler R
Eur J Cancer; 2017 May; 77():57-74. PubMed ID: 28365528
[TBL] [Abstract][Full Text] [Related]
58. "Alterations in the Skin Microbiota Are Associated With Symptom Severity in Mycosis Fungoides".
Zhang Y; Seminario-Vidal L; Cohen L; Hussaini M; Yao J; Rutenberg D; Kim Y; Giualiano A; Robinson LA; Sokol L
Front Cell Infect Microbiol; 2022; 12():850509. PubMed ID: 35656034
[TBL] [Abstract][Full Text] [Related]
59. Incidence of primary cutaneous T-cell lymphoma in Norway.
Saunes M; Nilsen TI; Johannesen TB
Br J Dermatol; 2009 Feb; 160(2):376-9. PubMed ID: 18808419
[TBL] [Abstract][Full Text] [Related]
60. [Mycosis fungoides and Sézary syndrome, so-called cutaneous T-cell lymphoma].
Rupniewska ZM
Postepy Hig Med Dosw; 1982; 36(4):231-49. PubMed ID: 6764803
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]